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Annular erythematous plaques on the right chest wall of a 55-year-old woman
Case report
A ﬁfty-ﬁve-year-old postmenopausal woman ﬁrst visited our dermatological department in February 2009 because of a history of progres-
sive appearance of annular pruritic plaques on the right chest wall for 1 month (Figure 1). She had went to multiple local medical doctors for
help; and under the impression of eczema or fungal infection, the patient was treated empirically with topical steroid and antifungal drugs,
but the therapeutic response was poor. On physical examination, an annular lesion with central clearing and erythematous border was
detected on her right chest wall. A potassium hydroxide preparation test was performed but no fungal elements were detected. Then a
diagnostic skin biopsy was performed (Figures 2A and 2B).Figure 1 Annular erythematous plaques on the right chest wall.
Figure 2 (A,B) Aggregates of tumor cells within the dilated endothelial lined spaces in
the upper dermis. (H&E, original magniﬁcation (A) 40; (B) 200).
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Figure 2 (C) The tumor cells within dermal lymphatic vessels were positive for Cyto-
keratin7 expression (original magniﬁcation200). H&E¼ hematoxylin and eosin stain.
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Inﬂammatory metastatic carcinoma.Discussion
The biopsy specimen from the erythematous border of the annular
lesion revealed aggregates of tumor cells within the dilated endo-
thelial lined spaces in the upper dermis (Figure 2A). The tumor
cells, which ﬁlled these dermal lymphatic vessels, had scant cyto-
plasm and hyperchromatic nuclei (Figure 2B). The immunohisto-
chemical study showed that these tumor cells were positive for
Cytokeratin 7 (Figure 2C) and negative for Cytokeratin 20. Tracing
back her history, shewas diagnosed with invasive ductal carcinoma
of the right breast in August 2008. She had received a modiﬁed
radical mastectomy, axillary lymph node dissection, and six cycles
of chemotherapy. The diagnosis of metastasis breast carcinoma
was conﬁrmed. Bone scan was performed and revealed multiple
metastases to the bone. Subsequently, the patient was treated
with various antineoplastic regimens, including chemotherapy
and radiation therapy. However, the patient did not respond to
these treatments and died in July 2009.
Breast cancer is the most common tumor that metastasizes to
skin and account for 24% of skin metastasis.1 Timucin et al2
reported that the most commonmetastatic area of skin from breast
caner is the chest wall (39%), the face (22.2%), the neck (9%), the
scalp (13.5%), and the abdominal wall and other localizations
(30.5%).
Several types of cutaneous metastases are unique to breast
cancer. Inﬂammatory skin metastases of carcinoma erysipelatoides
presents as an erysipelase-like patch or plaque with sharply
marginated borders. This type of lesion is secondary to dilated
dermal and subcutaneous lymphatics, which are plugged with
tumor cells. Our patient conformed to the diagnosis of inﬂamma-
tory skin metastases but did not have the characteristic clinical
presentation of carcinoma erysipelatoides. Annular erythematous
plaques are a rare presentation of breast cancer skin metastasis
and may be misdiagnosed if biopsy is not performed. Clinical
presentation of different skin diseases, including erythema annu-
lare centrifugum, erythema gyratum repens, and tinea infection,
may appear as ﬁgurate erythema, but the mechanism remains
obscure. Stone3 proposed that the distinctive characteristics ofﬁgurate dermatoses may be attributed to the localized ground
substance adaptive phenomenon with involvement of cellular
immunity modulation. The acute inﬂammatory reaction releases
connective tissue-active peptides (CTAP), which stimulate glycos-
aminoglycans and ﬁbroblast proliferation in the local papillae,
and may result in the formation of annular erythematous plaques.
CTAP triggers increased viscosity, elongation of dermal papillae and
capillaries producing edema, and may result in dilution of tissue
ﬂuids and spread of the inﬂammatory reaction to the adjacent
papillae. Under normal immune reactivity, CTAP should prevent
the spread of mediators and products of local inﬂammation.
However, in the host with highly reactive immune response, it
could terminate with the peripheral spread. The annular erythem-
atous plaques in our patient could be considered as a peculiar
immunologic hypersensitivity reaction of the host against the
tumor cells.3,4
Hu et al5 showed that the prognosis of patients with skin metas-
tasis of breast cancer depended on the advancement of the cancer.
In a study of Taiwanese population, the 1-, 3-, 5-, and 10-year cumu-
lative overall survival rates of breast cancer patients with only skin
metastasis were 79%, 51%, 37%, and 11%; and for those with skin and
visceral metastasis, the survival rates were 43%, 27%, 22%, and 0%,
respectively. These results indicated that breast cancer patients
with only skin metastasis have signiﬁcant better survival than those
with metastasis not conﬁned to the skin. In our patient, she was
found to have skin and bone metastasis and died within 1 year.
We emphasize that when a benign-looking skin lesion is resis-
tant to conventional therapy, searching for a detailed clinical
history, including an underlying malignancy, is important. There-
fore, in patients with a history of malignancy, skin biopsy should
be considered in all atypical or persistent inﬂammatory lesions.
The timely identiﬁcation of cutaneous metastases enables the
physician to suggest the most appropriate therapeutic plan, which
may ultimately prolong the survival of cancer patients.
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